Thursday, 18 Oct 2018

You are here

January/February 2016 Top Social Media News

In February 2016, RheumNow published 82 tweets about impactful news, research and teaching points that impact the rheumatology community. These feeds had a reach (impressions) of 80,800 with, 76 mentions, and over 2700 visits to learn on RheumNow.com.  The average daily “tweet” from RheumNow is seen by 3000-8,000, with as many as 89,500 viewers for a single tweet.  Our social media feeds are just one of several ways we deliver information to over 2500 rheumatologists and 2631 followers on Twitter. The following is a list of top tweets from January and February 2016; news items were selected based on the number of clicks, retweets and likes by the viewership.

  1. CDC issues a Zika Virus update: reviews those at risk and characteristic manifestations: acute fever, maculopapular rash, arthralgia, conjunctivitis, fetal loss, and microcephaly associated with pregnancy.  http://buff.ly/20nSiOz  This was published on 1/25/16 and had a reach of 89,500 viewers.
  2. JAMA Neurology publishes a population study showing that chronic use of proton pump inhibitors is associated with a higher risk of dementia.  Unclear if this association is causal or casual. http://buff.ly/20Aoblb  Published on 2/15/16 this post was viewed by 28,500.
  3. French guideline published on infection prevention in SLE; overall everyone needs influenza pneumococcal vaccination; avoid live virus vaccines, but no consensus on prophylaxis for pneumocystis.  http://buff.ly/20VVm2O  Published on 2/25/16, this report was viewed by 15,400.
  4. Posterior reversible encephalopathy syndrome (PRES) is a rare CNS manifestation in SLE.  Risk is more common in younger patients and higher in those with hypertension, renal insufficiency, high disease activity, lymphopenia, and interestingly, hyperlipidemia.  http://buff.ly/1Qn2iUZ  This report was posted on 2/29/16 and was seen by 15,400.
  5. A blog on Ten Ways that RA could’ve killed famous Eagle - Glenn Frey.  A major musical loss a reminder how behind we are in our management of RA. http://buff.ly/1Jrbxm4   Published on 1/23/16, it was seen by 14,700.
  6. The ocular manifestations of lupus are reviewed in BMJ.  Microangiopathy is the most common finding, but optic neuritis is not common or associated with CNS lupus.  http://buff.ly/1PvJ9hA  This was published on 1/2/16 and viewed by 14600.  
  7. FDA arthritis advisory committee reviewed a new biosimilar and voted 21-3 in favor of approving Celltrions’ CT-P13 (to be named Inflectra), a biosimilar of infliximab. http://buff.ly/1R1Cuwk  This was posted on the day of the meeting, 2/9/16, and was viewed by 14,500.
  8. Nurses health study (>77000) review shows that chronic (4 – 10 yrs.) use of non-aspirin NSAIDs was associated with a significantly higher (34%) increased future risk of renal cell carcinoma.  http://buff.ly/1OsevDr  This was published on 1/14/16 and seen by 13100.  
  9. Cohort review of IBD patients on Infliximab shows that drug induced skin manifestations are not uncommon (23%) and includes eczema and psoriasis like lesions - 41% these were exacerbations of underlying skin conditions.  http://buff.ly/1Kk5K27   Published on 2/16/16, the report was seen by 12000.
  10. Metanalyses shows use of the influenza vaccine in lupus is safe; does not induce lupus flares and is moderately effective; although seroconversion rates are lower in lupus patients.  http://buff.ly/1Q1MGEU  This was posted on 2/24/16 and seen by 8900 viewers.  

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

NEJM Debate on Medical Marijuana for Chronic Pain

This week’s NEJM features a case discussion and debate over whether medical marijuana should be used to treat chronic pain. The debate focuses on a 31-year-old woman with long-standing complex regional pain syndrome in her leg and foot. CRPS followed a sports related hairline fracture in the right fibula. Her pain has been intractable since.

Hip and Knee Replacements Monitored by Smart Watch

Reuters reports that patients with hip or knee replacements will now be followed for progress using their Apple watches.

A multi-site study involving medical facilities from Massachusetts, California, Colorado and Michigan will receive stats including heart rate, steps taken and standing hours from patients waiting for or recovering from hip and knee replacement surgery.

NSAIDs OK for Certain High-Risk Groups?

Some patients typically contraindicated for prescription nonsteroidal anti-inflammatory drug (NSAID) use may be able to take them with no increased risk of harm, according to a large observational study.

Physical Therapy Equals Arthroscopic Surgery in Meniscal Tears

Several new trials suggest that conservative management may be as efficacious as arthroscopic surgery in patients with meniscal tears, thus contributing to the trend of fewer arthroscopic surgeries. A new trial of patients with nonobstructive meniscal tears shows no significant difference in 2 year outcomes between physical therapy and early arthroscopic partial meniscectomy.

Activity Trackers May be Helpful in Arthritis Patients

Use of wearable activity trackers was associated with increases in the number of daily steps among individuals with rheumatic and musculoskeletal disorders, a meta-analysis found.